Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Palisade Bio
Research
Palisade's ulcerative colitis drug prevents symptoms in mice
Palisade Bio’s lead product candidate, a PDE4 inhibitor to treat the inflammatory bowel disease ulcerative colitis, appears to be effective in mice.
Helen Floersh
May 23, 2024 4:30am
Palisade's stock collapses as sole asset flunks phase 2 GI trial
Aug 9, 2023 10:35am
Former Roche pharma head to be new Bayer CEO—Chutes & Ladders
Feb 10, 2023 9:30am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
With cash evaporating quickly, Palisade Bio cuts 20% of staff
Sep 15, 2022 4:50pm
Seneca Biopharma merges with Leading BioSciences
Dec 17, 2020 8:18am
